Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-04-13 @ 5:49 PM
Study NCT ID:
NCT06563869
Status:
RECRUITING
Last Update Posted:
2024-08-21
First Post:
2024-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Sponsor:
Organization: